HB 4155
Plain-language analysis
Generated analysis, not an official summary or legal advice. Confirm with linked Oregon documents.
Requires most Oregon employer and individual health plans to cover specified fertility treatments, including IVF and cryopreservation, beginning January 1, 2027. Exempts certain insurers from direct coverage mandates but requires them to pay an actuarially equivalent fee into a new state-administered "Family Building Fund," which the Department of Consumer and Business Services uses to reimburse enrollees of those exempt plans for the same services.
Basis: Bill text · Source: House Amendments to Introduced
The measure addresses cost as a known barrier to fertility care, noting that limited insurance coverage restricts access for many individuals. It explicitly aims to mitigate inequity in the health insurance market by requiring actuarially equivalent fees from exempt insurers to fund reimbursement programs for their enrollees.
Basis: Official analysis · Source: Staff Measure Summary A
Inferred from cited text; not a stated purpose.
The legislative structure suggests a compromise to secure passage by protecting certain market segments from direct coverage mandates while using their fees to subsidize access for their enrollees. This is inferred from the explicit authorization to assess fees on exempt insurers "for the purpose of mitigating inequity" and the parallel creation of a DCBS-administered reimbursement pathway for those same plans.
Basis: Inferred · Source: House Amendments to Introduced
Gain mandated coverage for extensive fertility services, including IVF, egg retrieval, and cryopreservation.
Basis: Bill text · Source: House Amendments to Introduced
Do not receive direct plan coverage but gain access to state-administered reimbursements funded by insurer fees.
Basis: Bill text · Source: House Amendments to Introduced
Must either cover specified fertility services or pay an actuarially equivalent fee into the Family Building Fund if exempt from coverage requirements.
Basis: Bill text · Source: House Amendments to Introduced
Gains statutory authority, rulemaking power, and continuous appropriations to administer the reimbursement program and calculate assessment fees.
Basis: Bill text · Source: House Amendments to Introduced
Insurers must adjust plan designs, premium calculations, and claims processing by January 1, 2027. Enrollees gain access but may encounter network limitations or prior authorization processes not explicitly barred by the text (though step therapy is prohibited). DCBS will need to draft rules for fee calculation, program administration, and claim adjudication. Financial risk shifts from direct insurer payment to a pooled state fund mechanism for exempt plans, potentially altering premium dynamics across the market.
Basis: Bill text · Source: House Amendments to Introduced
Enrollee in an exempt plan
Successfully utilizes the DCBS reimbursement program to cover multiple IVF cycles and embryo storage without out-of-pocket costs, enabling family building that would otherwise be financially impossible.
Basis: Bill text · Source: House Amendments to Introduced
Small insurer or enrollee in a high-cost market
Faces severe premium increases or exits the Oregon market due to utilization of mandated fertility services, reducing consumer choice and leaving enrollees dependent on a potentially underfunded or administratively delayed DCBS reimbursement program.
Basis: Bill text · Source: House Amendments to Introduced
The text legally permits fee substitution for coverage mandates. Without rigorous actuarial oversight and clear claim adjudication standards, insurers could exploit valuation gaps to minimize payments while enrollees face administrative barriers to reimbursement.
Sources · House Amendments to Introduced
The measure trades direct insurer-funded coverage for a subset of plans in favor of a state-administered reimbursement pool funded by those same insurers, balancing expanded access against administrative complexity and potential premium volatility.
Broadens access to fertility care across the market.
Basis: Official analysis · Source: Staff Measure Summary A
Mitigates market inequity by ensuring enrollees in exempt plans receive equivalent financial support through the Family Building Fund.
Basis: Bill text · Source: House Amendments to Introduced
Introduces regulatory overhead and potential reimbursement delays for enrollees relying on the DCBS program.
Basis: Bill text · Source: House Amendments to Introduced
Shifts financial risk from private insurers to a public fund mechanism, potentially altering premium dynamics and requiring ongoing legislative oversight of the Family Building Fund's solvency.
Basis: Official analysis · Source: Staff Measure Summary A
The House Amendments version is substantively identical to the A-Engrossed version. Key editorial adjustments include explicit clarification that OEBB and PEBB coverage is opt-in rather than mandatory, removal of a prior study mandate on infertility access, and minor structural renumbering. No new substantive obligations or exemptions were introduced.
Clarified that OEBB and PEBB coverage requirements do not apply unless those boards elect to provide coverage, removing prior mandatory language.
Prevents automatic application of the mandate to state employee plans without explicit opt-in.
Sources · House Amendments to Introduced
Removed the requirement for OHA and DCBS to study infertility service access and report findings.
Streamlines implementation by eliminating a future reporting obligation.
Sources · House Amendments to Introduced
Tradeoff: The measure trades direct insurer-funded coverage for a subset of plans in favor of a state-administered reimbursement pool funded by those same insurers, balancing expanded access against administrative complexity and potential premium volatility.
high confidence. The measure text is explicit regarding coverage mandates, exemption pathways, fee structures, and fund creation. Official staff analysis confirms the legislative purpose and notes limited immediate revenue impact, though a more complete fiscal analysis is pending.
Possible effects if adopted; not current bill text.
If adopted, the amendment would require commercial health insurers to cover an expanded list of fertility treatments aligned with ASRM guidelines, while exempting certain plan types from direct coverage mandates. It creates a DCBS-administered reimbursement program and the Family Building Fund, financed by assessments on those exempt insurers, to pay for services for enrollees in exempt plans. The amendment removes automatic fertility coverage mandates for state employee (PEBB) and educator (OEBB) plans unless those boards opt in, and eliminates a previously required study on fertility care access.
Basis: Inferred · Sources: Amendment -6 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The amendment likely addresses administrative and cost concerns by shifting financial responsibility for certain plan types from direct insurer coverage mandates to a dedicated assessment-funded reimbursement pool, while removing automatic mandates for state-managed boards to allow them flexibility in benefit design.
Basis: Inferred · Sources: Amendment -6 — proposed amendment; Staff Measure Summary A
Must expand policy coverage to include a detailed list of fertility services, including egg retrieval limits, embryo transfers, storage, IVF, and related medications/surgery, while complying with ASRM guidelines.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Exempt from reimbursing specific embryo and IVF procedures but must pay new assessments into the Family Building Fund to finance reimbursements for their enrollees.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Gain access to a state-administered reimbursement program for covered fertility services, shifting cost responsibility from their insurer to the Family Building Fund.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Coverage is no longer automatically mandated; eligibility depends on whether the respective boards elect to adopt the requirements.
Basis: Inferred · Source: Amendment -6 — proposed amendment
DCBS must establish application processes, contract with third-party administrators, adopt rules, and collect assessments; the Treasury establishes and holds the Family Building Fund.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Insurers must update policy language, claims systems, and provider networks to cover the expanded service list and comply with ASRM-aligned single embryo transfer recommendations.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Exempt insurers face new assessment obligations calculated as the actuarial equivalent of costs attributed to the required coverage, with fees deposited into a dedicated state fund rather than the General Fund.
Basis: Inferred · Source: Amendment -6 — proposed amendment
DCBS will bear administrative costs and operational responsibility for claims processing, rulemaking, and program oversight, though the Legislative Revenue Office reports no analyzed impact on state or local revenues.
Basis: Inferred · Sources: Amendment -6 — proposed amendment; Revenue Impact Statement A
Enrollees gain broader access to fertility services, but the removal of the OHA/DCBS study eliminates a statutory mechanism for tracking financial barriers, utilization gaps, and equity disparities across demographics.
Basis: Inferred · Sources: Amendment -6 — proposed amendment; Staff Measure Summary A
Enrollee in a previously exempt plan
An individual receives full reimbursement through the DCBS program for three IVF cycles, multiple embryo transfers, and long-term storage, avoiding out-of-pocket expenses that would otherwise exceed $60,000 and enabling family building without financial hardship.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Small employer or self-insured plan sponsor
A plan falls under the exemption but faces assessment fees that are actuarially calculated to exceed projected claims, leading to significant premium increases for employees while DCBS reimbursement processing delays leave enrollees unable to access timely fertility care.
Basis: Inferred · Source: Amendment -6 — proposed amendment
The text legally permits assessment collection and plan exemptions but relies on accurate classification and consistent rulemaking to prevent cost-shifting or coverage gaps.
Sources · Amendment -6 — proposed amendment
The measure expands fertility care access and creates a dedicated funding mechanism for previously uncovered enrollees, but shifts financial responsibility to insurers via new assessments, removes automatic coverage mandates for state employee and educator plans, and eliminates a statutory study on equity barriers.
Standardizes coverage around ASRM clinical guidelines, reducing ambiguity in medical necessity determinations.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Establishes a dedicated revenue stream (Family Building Fund) to sustain reimbursements for exempt plan enrollees without drawing from the General Fund.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Removes automatic fertility coverage for PEBB and OEBB members, creating potential access disparities depending on board election timelines.
Basis: Inferred · Source: Amendment -6 — proposed amendment
Eliminates the OHA/DCBS study requirement, reducing legislative visibility into utilization patterns, cost barriers, and demographic equity gaps.
Basis: Inferred · Source: Amendment -6 — proposed amendment
high confidence. Analysis is grounded in the explicit text of the proposed amendment, staff measure summary, and fiscal statements. No enacted provisions or external litigation are referenced.
If adopted, the amendment would require commercial health insurers in Oregon to cover specified fertility treatments while exempting state employee and educator benefit plans (PEBB and OEBB) from that mandate unless those boards voluntarily opt in. It eliminates a planned legislative study on fertility care access, creates a new Family Building Fund, and directs DCBS to administer a reimbursement program funded by assessments on the exempted insurers.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The amendment may aim to preserve administrative and financial flexibility for state-managed benefit systems by allowing PEBB and OEBB to opt out of new fertility coverage mandates, while shifting the cost of covering those exempted members to a dedicated assessment fund rather than general state appropriations.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
Insurers must update policy language, provider networks, and claims processing to cover specified fertility treatments for all enrollees. Members gain mandated coverage but may face premium adjustments or plan design changes to accommodate the new requirement.
Basis: Inferred · Source: Staff Measure Summary A
Coverage depends on board election. If boards opt out, participants lose direct insurance coverage for fertility treatments but may become eligible for DCBS-administered reimbursements funded by the new Family Building Fund.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
Must pay assessments into the Family Building Fund to finance reimbursements for individuals with exempt plans, potentially increasing their operational costs or premium structures.
Basis: Inferred · Source: Staff Measure Summary A
OHA's statutory study role is removed. DCBS assumes new administrative duties to manage the reimbursement program, collect assessments, and disburse funds from the Family Building Fund.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
Commercial insurers will need to revise benefit designs, update claims adjudication systems, and coordinate with reproductive endocrinology providers to comply with the new coverage mandate before plan year 2027.
Basis: Inferred · Source: Staff Measure Summary A
PEBB and OEBB boards must convene to evaluate opt-in feasibility, creating administrative steps and potential coverage gaps if decisions are delayed near the January 2027 effective date.
Basis: Inferred · Source: Amendment -5 — proposed amendment
Individuals with exempt plans will need to navigate a new DCBS reimbursement application process rather than receiving direct insurance coverage, introducing potential delays and administrative friction.
Basis: Inferred · Source: Staff Measure Summary A
Assessment calculations for the Family Building Fund will require actuarial modeling to ensure sufficient revenue to cover projected claims without overburdening exempt insurers or triggering premium spikes.
Basis: Inferred · Source: Staff Measure Summary A
State employee or educator plan member requiring complex fertility treatment
Despite PEBB/OEBB opting out, the Family Building Fund is fully capitalized and DCBS processes reimbursements rapidly. The member receives full coverage for IVF and related procedures without waiting for board action, maintaining timely access to care while preserving state system flexibility.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
Exempt insurers and DCBS
Assessments collected from exempt insurers prove insufficient due to higher-than-expected fertility treatment utilization or legal challenges to the fee structure. The Family Building Fund depletes rapidly, leaving DCBS unable to reimburse eligible claims and forcing a coverage gap for thousands of state/educator plan members.
Basis: Inferred · Sources: Amendment -5 — proposed amendment; Staff Measure Summary A
inference
Sources · Amendment -5 — proposed amendment; Staff Measure Summary A
Mandating commercial fertility coverage expands access for private plan holders but shifts financial and administrative burdens onto state benefit systems and a new assessment-funded reimbursement program.
Guarantees standardized fertility treatment coverage across the commercial market, reducing geographic and employer-based disparities.
Basis: Inferred · Source: Staff Measure Summary A
Preserves PEBB/OEBB flexibility to manage state benefit costs and plan design without forced compliance.
Basis: Inferred · Source: Amendment -5 — proposed amendment
Creates a dedicated funding stream that isolates fertility treatment costs from general state budgets.
Basis: Inferred · Source: Staff Measure Summary A
Introduces new regulatory compliance costs and potential premium increases for commercial insurers.
Basis: Inferred · Source: Staff Measure Summary A
Removes a planned legislative study on equity, access barriers, and federal funding opportunities for fertility care.
Basis: Inferred · Source: Amendment -5 — proposed amendment
Relies on assessment-based funding that may prove volatile or insufficient if utilization exceeds projections or legal challenges arise.
Basis: Inferred · Source: Staff Measure Summary A
high confidence. Analysis is grounded in the provided amendment text, staff measure summary, and fiscal notices. Inferences are explicitly labeled and bounded to the supplied documents.
The amendment would remove mandatory fertility treatment coverage requirements from the Public Employees’ Benefit Board (PEBB) and Oregon Educators Benefit Board (OEBB), leaving commercial employer and individual health plans as the primary entities subject to the mandate, while establishing a Department of Consumer and Business Services (DCBS)-administered reimbursement program funded by assessments on exempt insurers. If adopted, coverage for state employees and educators would no longer be automatically guaranteed under this measure, and commercial insurers would face new benefit design obligations starting January 1, 2027.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The amendment likely reflects a legislative compromise aimed at mitigating insurer cost concerns and potential premium impacts by carving out public-sector mandates and creating an exemption pathway with a dedicated funding mechanism for affected enrollees.
Basis: Inferred · Source: Staff Measure Summary A
Must provide coverage for specified fertility treatments (including IVF, IUI, storage, and medications) to all plan members, including spouses and dependents, without step therapy or exclusions based on third-party involvement. Coverage applies to plans beginning in the 2027 plan year.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
No longer automatically entitled to statutory fertility coverage under this bill. Coverage decisions shift to the respective benefit boards, which may opt in or maintain existing voluntary benefits.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
May avoid direct coverage of embryo transfer, storage, thawing, hatching, and IVF, but must pay assessments into the Family Building Fund to subsidize DCBS-administered reimbursements for their enrollees.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
DCBS assumes administration of the reimbursement program and Family Building Fund, with appropriations drawn from assessments. OHA’s statutory study on fertility access is removed.
Basis: Inferred · Source: Staff Measure Summary A
Commercial plans must update policy language, adjust premium rating models, and coordinate with reproductive endocrinology networks to meet the January 1, 2027 operative date.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
Exempt insurers face a new compliance and assessment obligation, shifting financial responsibility for uncovered embryo-related services from direct care provision to a centralized reimbursement pool.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
State and educator benefit members lose automatic statutory coverage guarantees, potentially creating access disparities depending on PEBB/OEBB board decisions and existing plan designs.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
DCBS will require rulemaking to define assessment rates, reimbursement procedures, and provider eligibility for the Family Building Fund program.
Basis: Inferred · Source: Staff Measure Summary A
Commercial enrollee with medically necessary IVF
A plan member diagnosed with infertility receives full coverage for three oocyte retrievals, unlimited embryo transfers, and associated medications without step therapy or prior authorization delays, avoiding out-of-pocket costs that previously exceeded $50,000 and enabling timely family building.
Basis: Inferred · Source: Staff Measure Summary A
Enrollee in an exempt insurer plan
An enrollee relies on the DCBS Family Building Fund for embryo-related services but encounters narrow provider networks, lengthy reimbursement processing times, and coverage caps that leave them with substantial residual costs and delayed care.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
The distinction rests on whether exemption claims are narrowly applied to specific services per the statute versus broadly used to circumvent the mandate’s intent, compounded by potential administrative delays in DCBS program implementation.
Sources · Amendment -4 — proposed amendment; Staff Measure Summary A
The measure expands fertility coverage mandates in the commercial market while removing automatic guarantees for state and educator employees, funding a public reimbursement safety net through insurer assessments.
Commercial enrollees gain standardized, medically necessary fertility coverage without step therapy or third-party participation exclusions.
Basis: Inferred · Source: Staff Measure Summary A
Exempt insurers retain benefit design flexibility while contributing to a dedicated fund that supports enrollees who cannot access direct coverage.
Basis: Inferred · Source: Staff Measure Summary A
Fragmented coverage landscape creates access disparities between commercial plans and public-sector employees.
Basis: Inferred · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
DCBS program administration and assessment collection introduce new compliance costs and potential delays in reimbursement processing.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
high confidence. The amendment text, staff summary, and fiscal impact statement provide clear structural changes, operative dates, and funding mechanisms. Remaining uncertainties relate to implementation rules, actuarial data, and board decisions not yet published.
If adopted, the amendment mandates comprehensive fertility treatment coverage for employer and individual health plans, creates a Department of Consumer and Business Services (DCBS) administered reimbursement safety net for enrollees in legally exempt insurer plans, and funds this program through actuarially equivalent assessments on those exempt insurers deposited into a dedicated Family Building Fund.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
Legislators are using an assessment-and-reimbursement mechanism to expand fertility coverage access without directly forcing all insurers to bear the full mandate cost, potentially to ease industry opposition or navigate existing exemption frameworks.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Gain mandated coverage for extensive fertility services, including specific retrieval limits, cryopreservation, IVF, IUI, and related diagnostics, with step therapy prohibited.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Will not receive direct coverage but gain access to DCBS-administered reimbursements for covered procedures, funded by a dedicated state assessment program.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Face new actuarially equivalent assessments to fund the reimbursement program, with no requirement to provide or pay for covered services directly.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Gain administrative authority, rulemaking power, and continuous appropriations to establish application processes, process claims, and manage the Family Building Fund.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Insurers must adjust premium calculations to include new assessments and comply with DCBS rulemaking for assessment rates. Enrollees in exempt plans must navigate a new DCBS application process for reimbursements. Providers will bill either the primary plan or the DCBS program. Premiums for exempt insurers may rise due to assessments, while fund sustainability depends on assessment rates matching actual claim volumes and costs.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Enrollee in an exempt plan with complex infertility needs
Successfully navigates the DCBS application process and receives full reimbursement for six lifetime egg retrievals, unlimited embryo transfers, and all associated cryopreservation and diagnostic services, avoiding out-of-pocket costs that typically exceed $100,000.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Enrollees in exempt plans at a high-utilization employer
A concentrated cohort of individuals requiring extensive retrieval cycles triggers assessment rates that significantly increase premiums for all policyholders in exempt plans, potentially making coverage unaffordable or prompting insurers to withdraw from the Oregon market.
Basis: Bill text · Source: Amendment -1 — proposed amendment
The text authorizes actuarially equivalent assessments and DCBS rulemaking authority but does not mandate ongoing audit mechanisms or explicit penalties for exemption misclassification.
Sources · Amendment -1 — proposed amendment
Expands guaranteed access to fertility treatments for all Oregon residents but bifurcates coverage delivery and imposes new assessment-driven premium costs on insurers that previously operated under exemption frameworks.
Standardized care access reduces out-of-pocket barriers for infertility treatment across both fully insured and exempt plan markets.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Dedicated funding stream and continuous appropriation provide predictable administrative resources for DCBS to manage claims without competing with general fund priorities.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Administrative complexity increases for enrollees, providers, and insurers due to bifurcated coverage pathways and new application/reimbursement processes.
Basis: Bill text · Source: Amendment -1 — proposed amendment
Premium volatility risk for exempt plans if assessment rates fail to accurately predict utilization, potentially shifting costs unpredictably to policyholders.
Basis: Bill text · Source: Amendment -1 — proposed amendment
high confidence. Analysis is strictly derived from the provided proposed amendment text, staff measure summary, and fiscal impact statements. No external speculation or legislative intent assumptions were applied.
If adopted, the amendment would require private health insurers to cover expanded fertility treatments while permitting an exemption for embryo-related procedures (IVF, storage, thawing, hatching, and transfer). It establishes a Family Building Fund financed by assessments on exempt insurers to reimburse enrollees with those plans, removes mandatory coverage requirements for PEBB and OEBB, eliminates a planned legislative study on fertility access, and sets an effective date of January 1, 2027.
Basis: Bill text · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The amendment likely seeks to expand baseline fertility coverage while accommodating ethical or cost objections to embryo-related procedures by creating a targeted exemption and a dedicated reimbursement mechanism, thereby reducing insurer resistance and legislative friction.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
Must cover expanded fertility services but may opt out of embryo-related procedures. Opting out triggers an assessment into the Family Building Fund and shifts reimbursement administration to DCBS for affected enrollees.
Basis: Bill text · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
Gain access to a state-administered reimbursement program for covered fertility services previously excluded by their insurer, subject to DCBS program implementation timelines.
Basis: Bill text · Source: Staff Measure Summary A
No longer automatically mandated to receive coverage; benefit boards may opt in, potentially creating coverage variability among public employees and educators.
Basis: Bill text · Sources: Amendment -4 — proposed amendment; Staff Measure Summary A
Assumes new administrative duties to collect assessments, manage the Family Building Fund, process reimbursements, and enforce exemption compliance.
Basis: Bill text · Sources: Staff Measure Summary A; Fiscal Impact Statement A
Insurers will need to update policy language, adjust actuarial pricing models, and modify claims workflows to reflect expanded mandatory coverage and the new exemption/assessment structure.
Basis: Bill text · Source: Staff Measure Summary A
Enrollees may experience administrative delays or benefit gaps while DCBS establishes the reimbursement program and collects sufficient assessments from exempt insurers.
Basis: Bill text · Source: Staff Measure Summary A
Premium volatility may occur depending on the proportion of insurers claiming the exemption versus absorbing full embryo-related treatment costs, alongside potential rate adjustments to fund assessments.
Basis: Bill text · Source: Staff Measure Summary A
PEBB and OEBB will require separate legislative or board action to maintain coverage parity with the private market, potentially delaying uniform public sector benefits.
Basis: Bill text · Source: Amendment -4 — proposed amendment
Enrollees with exempt plans
A high volume of insurers claim the exemption, but DCBS efficiently funds and processes reimbursements through the Family Building Fund, enabling enrollees to access IVF and related services without out-of-pocket costs exceeding $25,000 per cycle while preserving insurer flexibility.
Basis: Bill text · Source: Staff Measure Summary A
Enrollees with exempt plans and DCBS
Insurers delay or underpay assessments, overwhelming DCBS with reimbursement claims before adequate funding is collected, resulting in prolonged benefit delays, administrative backlogs, and potential rate spikes for insurers bearing the assessment burden.
Basis: Bill text · Source: Staff Measure Summary A
The statutory language permits a targeted exemption tied to a funding mechanism; misuse would stem from administrative delay, classification errors, or premium shifting rather than explicit statutory authorization.
Sources · Amendment -4 — proposed amendment; Staff Measure Summary A
Expanding mandatory fertility coverage access while allowing an exemption for embryo-related procedures balances broader treatment availability against insurer cost concerns and ethical objections, but shifts administrative complexity and potential reimbursement delays to DCBS and enrollees with exempt plans.
Increases baseline coverage breadth for infertility treatments across the private market.
Basis: Bill text · Source: Staff Measure Summary A
Creates a dedicated funding mechanism (Family Building Fund) to support enrollees whose insurers opt out of embryo-related services.
Basis: Bill text · Source: Staff Measure Summary A
Reduces legislative friction by removing mandatory PEBB/OEBB mandates and a study requirement, potentially accelerating passage.
Basis: Bill text · Source: Amendment -4 — proposed amendment
Imposes new administrative and financial burdens on DCBS to collect assessments, manage the fund, and process reimbursements.
Basis: Bill text · Source: Staff Measure Summary A
Creates coverage fragmentation for PEBB/OEBB members who may not opt in, potentially affecting public sector benefit parity.
Basis: Bill text · Source: Amendment -4 — proposed amendment
Premium volatility and assessment collection delays could strain insurers or leave enrollees without timely reimbursement access.
Basis: Bill text · Source: Staff Measure Summary A
high confidence. Analysis is grounded in the official committee amendment text, staff measure summary, and fiscal impact statements. No enacted language or external litigation is assumed.
If adopted, HB 4155-1 would mandate comprehensive fertility treatment coverage for employer and individual health plans while creating a parallel state-administered reimbursement program funded by assessments on insurers that claim exemptions from covering embryo-related services. The measure redirects existing insurance industry assessments to a new Family Building Fund administered by DCBS, effectively shifting the financial burden of covered fertility care from participating insurers to those claiming exemptions and establishing a separate claims infrastructure for exempt-plan enrollees.
Basis: Inferred · Sources: Amendment -1 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The amendment likely aims to balance broad fertility coverage mandates with insurer cost-containment concerns by allowing exemptions while ensuring enrollees retain access through a dedicated state-administered fund. This is inferred from the text's structural pairing of an insurer exemption with a DCBS reimbursement program and a dedicated funding stream, which addresses potential rate-sensitivity or administrative pushback against unfunded coverage mandates.
Basis: Inferred · Sources: Amendment -1 — proposed amendment; Staff Measure Summary A
Gain statutory entitlement to specified fertility treatments (e.g., IVF, IUI, cryopreservation) with defined retrieval limits and unlimited embryo transfers, applicable to all plan members including spouses and dependents.
Basis: Inferred · Source: Amendment -1 — proposed amendment
May opt out of covering embryo transfer and related procedures but must pay assessments to the Family Building Fund calculated as the actuarial equivalent of coverage costs.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Gain access to a DCBS-administered reimbursement program for covered fertility services, shifting claim processing from their private insurer to a state-contracted third-party administrator.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Gains administrative authority to set application processes, contract with third-party administrators, collect assessments, and allocate funds to the Family Building Fund.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Participating insurers must cover a defined basket of fertility services without step therapy or exclusions based on third-party involvement, starting in plan year 2027.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Exempt insurers face new assessment obligations that may increase premiums if actuarial calculations underestimate actual claim volumes or utilization rates.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Enrollees gain guaranteed access to treatments but must navigate a separate state application and claims infrastructure rather than standard insurer networks, potentially altering provider selection and reimbursement timelines.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Enrollee with complex fertility diagnosis
Receives full coverage for six lifetime egg retrievals, unlimited embryo transfers, and associated cryopreservation/storage without out-of-pocket costs or step-therapy delays, enabled by the DCBS program when their insurer claims an exemption.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Small employer plan or exempt insurer
Faces significant premium increases due to high utilization of covered fertility services, while the Family Building Fund experiences shortfalls if assessments are miscalculated or claim volumes exceed actuarial projections, potentially leading to delayed reimbursements or coverage gaps before legislative adjustment.
Basis: Inferred · Source: Amendment -1 — proposed amendment
The text permits exemptions and assessment-based funding but does not specify strict audit mechanisms or claim adjudication standards, creating room for misclassification or duty creep in reimbursement eligibility.
Sources · Amendment -1 — proposed amendment
The measure expands guaranteed access to fertility care for enrollees but shifts financial and administrative complexity from private insurers to a state-managed assessment-funded program, creating tradeoffs between coverage certainty and premium stability.
Standardized coverage reduces treatment delays and geographic/provider disparities; dedicated funding ensures reimbursement continuity regardless of insurer participation.
Basis: Inferred · Source: Amendment -1 — proposed amendment
Assessment-driven funding may increase premiums for exempt plans; DCBS administration introduces bureaucratic layers that could delay claims or create compliance burdens for providers and enrollees.
Basis: Inferred · Source: Amendment -1 — proposed amendment
high confidence. Analysis is grounded in the explicit statutory text of the proposed amendment, staff measure summary, and fiscal impact statements. All impacts are conditional on adoption and explicitly distinguished from enacted law.
22 records currently loaded
Records available in the current snapshot.
Earliest loaded signal
Introduced bill text posted
Posted Jan 28, 2026, 3:25 PM PST
Follow the official text for HB 4155 and every amendment branch. Connections come from each amendment's stated base. Horizontal position shows when each document was first posted, when available. Dotted links flag likely related proposals based on their text.
Click a card to isolate its connected lines; use View summary to jump to its details. Horizontal position shows first posting time in Pacific Time. Drag or use the arrow keys to pan. Pinch with two fingers on mobile, or zoom with the controls, +/− keys, or Control/Command + scroll; press 0 to reset. Dashed branches remained proposals. Dotted teal links are text-based early signals, not official amendment relationships.
Selected document summary
Substantial replacement
What the document says to change
delete lines 7 through 12 and insert:
Inferred policy relationships
Likely revised proposal · Amendment -6
High confidence from shared inserted text: ORS 646, ORS 705.145, ORS 731.292, ORS 731.804, ORS 731.820, Tax deduction, Program administration.
This is a text-based early signal, not an official statement that one amendment changes the other.
No deeper official pre-number history was found.
Chief sponsors: Representative Lucetta Elmer
Regular sponsors: Representative Court Boice, Representative Matt Bunch, Representative Darcey Edwards, Representative Jeffrey Helfrich, Representative Bobby Levy, Representative Rick Lewis, Representative Kevin Mannix, Representative Emily McIntire, Representative Virgle Osborne, Representative Anna Scharf, Representative Alek Skarlatos, Representative Dwayne Yunker, Representative David Gomberg, Representative Emerson Levy, Representative Zach Hudson, Representative Dacia Grayber
Records already listed in Activity are not repeated here.
Official origin records are incomplete; missing facts are not inferred.
The artifact has broad business or technology relevance, but it does not identify a concrete effect on Yex Labs LLC.
74% confidence · deterministic fallback
22 events
Full timeline
22 entries shown.
In committee upon adjournment.
House Amendments to Introduced bill text posted
Referred to Ways and Means by prior reference.
Recommendation: Do pass with amendments, be printed A-Engrossed, and be referred to Ways and Means by prior reference.
Work Session held.
Amendment -6 adopted
IS_Impact HB 4155 5
Revenue Impact Statement
Amendment -5 combined
IS_Impact HB 4155 4
Revenue Impact Statement
IS_Impact HB 4155 1
Revenue Impact Statement
Amendment -4 proposed
Amendment -1 combined
Public Hearing held.
Amendment -4 proposed
Amendment -1 proposed
Referred to Health Care with subsequent referral to Ways and Means.
First reading. Referred to Speaker's desk.
. HA to HB 4155 Page 2 1 “ SECTION 7. ORS 731.292, as amended by section 16, chapter 4, Oregon Laws 2025, is amended 2 to read: 3 “731.292. (1) Except as provided in subsections [(2)
ection 5 of this 2026 Act. 19 SECTION 7. ORS 731.292, as amended by section 16, chapter 4, Oregon Laws 2025, is amended 20 to read: 21 731.292. (1) Except as provided in subsections [(2)
to include qualifying fertility services, including ART up to $25,000 annually. House Bill 2959 (2025) would have required employer and individual health plans to reimburse th
“Digest: The Act tells some insurers to cover care for some fertility treatments and exempts some insurers from parts of this requirement. Tells DCBS to make a program to cover costs for exempt insurers. Creates a new fund. (Flesch Readability Score: 66.2). [ Digest: The Act tells some insurers, OEBB and PEBB to cover care for some fertility treatments. The Act tells OHA and DCBS to study access to reproductive treatments and report back to the committee on health. The Act makes it an emergency. (Flesch Readability Score: 65.0). ] Requires certain health insurers[ , the Oregon Educators Benefit Board and the Public Employees' Benefit Board ] to cover fertility services and treatments. Exempts certain insurers from specific coverage requirements. [ Directs the Oregon Health Authority and the Department of Consumer and Business Services to study access to fertility and reproductive endocrinology services and report findings to the interim committees of the Legislative Assembly related to health. ] [ Declares an emergency, effective on passage. ] Directs the Department of Consumer and Business Services to administer a program to provide reimbursement for the costs for treatments when not covered by exempted insurers. Establishes the Family Building Fund in the State Treasury.”
Oregon updates this record in place. This page uses the latest text; an exact original snapshot is unavailable.
Confirm with the official record.
Supplemental, source-linked analysis from project researchers and community contributors. It is separate from Oregon's official record.